Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of MXN 190.03 billion. The enterprise value is 45.50 billion.

Market Cap	190.03B
Enterprise Value	45.50B

Important Dates

The next estimated earnings date is Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	386.74M
Shares Outstanding	n/a
Shares Change (YoY)	+1.05%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	360.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.93
PB Ratio	0.92
P/TBV Ratio	0.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.66
EV / Sales	0.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.55

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.07.

Current Ratio	4.22
Quick Ratio	3.92
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.19
Interest Coverage	-196.26

Financial Efficiency

Return on equity (ROE) is -29.34% and return on invested capital (ROIC) is -18.75%.

Return on Equity (ROE)	-29.34%
Return on Assets (ROA)	-15.84%
Return on Invested Capital (ROIC)	-18.75%
Return on Capital Employed (ROCE)	-33.59%
Revenue Per Employee	11.20M
Profits Per Employee	-11.83M
Employee Count	5,800
Asset Turnover	0.22
Inventory Turnover	27.39

Taxes

Income Tax	-1.00B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.56% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-81.56%
50-Day Moving Average	515.15
200-Day Moving Average	834.23
Relative Strength Index (RSI)	45.29
Average Volume (20 Days)	2,034

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.16

Income Statement

In the last 12 months, Moderna had revenue of MXN 64.93 billion and -68.61 billion in losses. Loss per share was -178.35.

Revenue	64.93B
Gross Profit	-53.49B
Operating Income	-76.22B
Pretax Income	-69.61B
Net Income	-68.61B
EBITDA	-72.29B
EBIT	-76.22B
Loss Per Share	-178.35

Full Income Statement

Balance Sheet

The company has 122.12 billion in cash and 15.23 billion in debt, giving a net cash position of 156.32 billion.

Cash & Cash Equivalents	122.12B
Total Debt	15.23B
Net Cash	156.32B
Net Cash Per Share	n/a
Equity (Book Value)	205.74B
Book Value Per Share	531.62
Working Capital	105.51B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -62.38 billion and capital expenditures -19.87 billion, giving a free cash flow of -82.25 billion.

Operating Cash Flow	-62.38B
Capital Expenditures	-19.87B
Free Cash Flow	-82.25B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -82.37%, with operating and profit margins of -117.37% and -105.67%.

Gross Margin	-82.37%
Operating Margin	-117.37%
Pretax Margin	-107.21%
Profit Margin	-105.67%
EBITDA Margin	-111.33%
EBIT Margin	-117.37%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.05%
Shareholder Yield	n/a
Earnings Yield	-36.11%
FCF Yield	-43.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 7.39 and a Piotroski F-Score of 2.

Altman Z-Score	7.39
Piotroski F-Score	2